DPP-4 Inhibition May Reduce Atherogenesis in HIV
Treatment with sitagliptin had no effect on soluble CD14 when given to participants with virally suppressed HIV infection.
Endocrinology
Switching to Raltegravir or Dolutegravir Improves Leptin and Insulin in HIV
Switching from a protease inhibitor to raltegravir or dolutegravir was effective in improving insulin sensitivity, and reduced lipid parameters in PLWHIV.
Next post in HIV/AIDS
